Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04109599 · ClinicalTrials.gov registry record · NA
A Digital Intervention to Prevent Initiation of Opioid Misuse in Adolescents in School-based Health Centers
A NA study of Opioid Misuse, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
- 1
- Study location
NCT04109599: Completed NA study of Opioid Misuse, sponsored by Yale University.
NCT04109599 is a NA study of Opioid Misuse that has completed, run by Yale University. The registered enrollment target is 33 participants, below the 5,988-participant average among 13 other Opioid Misuse trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04109599, a NA study of Opioid Misuse, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
- 1
- Study location
Study Summary
This study's specific aims were to: develop a digital intervention as a prevention intervention through focus groups with 40 youth; pilot-test the developed digital intervention with 30 adolescents, using methods from the investigator's prior research; develop implementation strategies and partners through focus groups with 50 School Based Health Alliance affiliates and 30 adolescents from an Advisory Council.
Primary Outcome
Participants were asked 5 true/false knowledge questions pre/post gameplay.
Conditions Studied
Interventions
- BEHAVIORAL PlaySmart
- BEHAVIORAL PlaySmart Storyline
- BEHAVIORAL Play Smart Mini-Game
Study Locations (1)
Connecticut
- Yale School of Medicine - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2021-03-01 |
| Est. Completion | 2021-08-31 |
| Phase | NA |
What the finished NCT04109599 record still lists
NCT04109599 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 5,988-participant average among 13 other Opioid Misuse trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Opioid Misuse appearing as the primary indexed condition, and to 3 interventions - of which PlaySmart is the first listed.
NCT04109599 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT04109599 about?
NCT04109599 is a clinical study titled "A Digital Intervention to Prevent Initiation of Opioid Misuse in Adolescents in School-based Health Centers". This study's specific aims were to: develop a digital intervention as a prevention intervention through focus groups with 40 youth; pilot-test the developed digital intervention with 30 adolescents, using methods from the investigator's prior research; develop implementation strategies and partners ...
What is the current status of trial NCT04109599?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2021-03-01. Estimated completion is 2021-08-31.
What conditions does trial NCT04109599 study?
This clinical trial studies the following conditions: Opioid Misuse.
What interventions are being tested in trial NCT04109599?
The interventions under investigation include: PlaySmart (BEHAVIORAL), PlaySmart Storyline (BEHAVIORAL), Play Smart Mini-Game (BEHAVIORAL).
Who is sponsoring clinical trial NCT04109599?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04109599 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Misuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04109599's enrollment target sits among peer trials
33 14th of 13 the lowest of 13 other Opioid Misuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Misuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
-
M2VA Pain Care Pathway
RECRUITING · NA
-
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
RECRUITING · NA
-
Pain Care at Home to Amplify Function (Pain CHAMP)
ACTIVE NOT RECRUITING · NA
-
Healthy Opioid Prescription Engagement
ACTIVE NOT RECRUITING · NA
-
Reduced Opioid Prescription After Laparoscopic Hysterectomy
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI